Skip to content

Movement Analysis in Musculoskeletal Oncology: a Pilot Study

Movement Analysis in Musculoskeletal Oncology: a Pilot Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05918549
Acronym
AnMov
Enrollment
30
Registered
2023-06-26
Start date
2022-09-28
Completion date
2024-09-28
Last updated
2024-01-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Motion Analysis in Musculoskeletal Oncology

Brief summary

Noninterventional, prospective, multicenter pilot study of patients with primary and secondary musculoskeletal tumors designed to investigate functional outcomes after therapy using both subjective and quantitative motion detection techniques

Interventions

DEVICEMotion Analysis in Musculoskeletal Oncology

Noninterventional, prospective, multicenter pilot study of patients with primary and secondary musculoskeletal tumors designed to investigate functional outcomes after therapy using both subjective and quantitative motion detection techniques

Sponsors

Azienda Policlinico Umberto I
CollaboratorOTHER
Università degli studi di Roma Foro Italico
CollaboratorOTHER
Regina Elena Cancer Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
6 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 6 years * Diagnosis of primary and secondary tumors of the musculoskeletal system * Patients who will need to undergo surgery for bone resection or wide excision of soft tissue lesion, and/or radiation or drug treatments * Availability of follow-up data (for at least 6 months) * Written informed consent

Exclusion criteria

\- Inability to perform pre-post treatment assessment

Design outcomes

Primary

MeasureTime frameDescription
Quality of lifeBaselineTo investigate any differences found using the two methods (quantitative/movement analysis technique versus subjective/qualitative technique) in changes in walking/motor characteristics in post-treatment versus pre-treatment. Patients will be monitored via a system of wearable sensors (OPAL 15) which send signals to a computer - station receiving. The system is equipped with 15 small, wireless devices and non-invasive, which contain the following sensors: i) triaxial accelerometer for measuring linear accelerations of the body segment; ii) triaxial gyroscope for measuring angular speeds; iii) triaxial magnetometer, essential for estimating the orientation of the segment in space corporeal. The system synchronously acquires data from each device and sends it via telemetry to one control unit that collects them and saves them in the local database of the computer used for the acquisition.

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026